Cefiderocol (S-649266) is a siderophore-conjugated cephalosporin antibiotic for research use. It demonstrates potent in vitro and in vivo activity against multidrug-resistant aerobic Gram-negative bacteria, including carbapenem-resistant strains, making it a valuable tool for studying novel antimicrobial mechanisms and infection models.
